UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A091WJF3 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A091WK56 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A091VVH9 | Potassium channel subfamily K member 16 (Fragment) |
|
1 | 0 |
|
A0A091WMX4 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A091V6J4 | Peptidyl-glycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A091W1T3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A091W6A5 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A091WJN3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A091W747 | Cathepsin D (Fragment) |
|
2 | 0 |
|
A0A091VI83 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A091VZ76 | Beta-secretase 2 (Fragment) |
|
1 | 0 |
|
A0A091VN92 | ATP receptor (Fragment) |
|
1 | 0 |
|
A0A091VYI4 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A091VM64 | Phosphoinositide phospholipase C (Fragment) |
|
1 | 0 |
|
A0A091W5M6 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A091WM78 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A091W7U1 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A091VQJ1 | P2X purinoceptor |
|
1 | 0 |
|
A0A091VJG7 | Angiotensin-converting enzyme (Fragment) |
|
2 | 0 |
|
A0A091WFB4 | Proto-oncogene tyrosine-protein kinase receptor Ret (Fragment) |
|
1 | 0 |
|
A0A091XRS4 | Noggin (Fragment) |
|
1 | 0 |
|
A0A091W911 | Paraoxonase (Fragment) |
|
3 | 0 |
|
A0A091W7D6 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A091VFK0 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A091VEG3 | Rhodopsin |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024